Kawanishi; Eiji

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kawanishi; Eiji.The latest application filed is for "glucopyranoside compound".

Company Profile

1.12.15

Kawanishi; Eiji - Osaka JP
KAWANISHI; Eiji - Kitamoto-shi JP
KAWANISHI; Eiji - Osaka-shi Osaka
Kawanishi; Eiji - Kitamoto JP
Kawanishi; Eiji - Kawasaki-si JP
Kawanishi; Eiji - Otsu JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bridged nucleic acid GuNA, method for producing same, and intermediate compound Grant 10,961,269 - Obika , et al. March 30, 2	2021-03-30
Glucopyranoside Compound App 20180282363 - NOMURA; Sumihiro ; et al.	2018-10-04
Crosslinked Nucleic Acid Guna, Method For Producing Same, And Intermediate Compound App 20180251488 - OBIKA; Satoshi ; et al.	2018-09-06
Glucopyranoside Compound App 20160108078 - NOMURA; Sumihiro ; et al.	2016-04-21
Pyrazolopyrimidine compounds and their use as PDE10 inhibitors Grant 8,969,376 - Kawanishi , et al. March 3, 2	2015-03-03
Glucopyranoside Compound App 20140296506 - NOMURA; Sumihiro ; et al.	2014-10-02
Glucopyranoside compound Grant 8,785,403 - Nomura , et al. July 22, 2	2014-07-22
Hybrid Power Generator Coupled To Gravity Power Generator Using Balance Which Has Pressure Load Device App 20130341934 - Kawanishi; Eiji	2013-12-26
Crystalline form of 1-(.beta.-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethy- l]benzene hemihydrate Grant 8,513,202 - Nomura , et al. August 20, 2	2013-08-20
Pyrazolopyrimidine Compounds And Their Use As Pde10 Inhibitors App 20120309754 - Kawanishi; Eiji ; et al.	2012-12-06
Glucopyranoside Compound App 20120258913 - NOMURA; Sumihiro ; et al.	2012-10-11
Glucopyranoside compound Grant 8,222,219 - Nomura , et al. July 17, 2	2012-07-17
Glucopyranoside compound Grant 8,202,984 - Nomura , et al. June 19, 2	2012-06-19
Glucopyranoside Compound App 20120058941 - NOMURA; Sumihiro ; et al.	2012-03-08
Crystalline Form Of 1-(beta-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]- Benzene Hemihydrate App 20110212905 - Nomura; Sumihiro ; et al.	2011-09-01
Aromatic Nitrogen-containing 6-membered Ring Compounds And Their Use App 20110166135 - Morimoto; Hiroshi ; et al.	2011-07-07
Tri-substituted Pyrimidine Compounds And Their Use As Pde10 Inhibitors App 20110160206 - Kawanishi; Eiji ; et al.	2011-06-30
Glucopyranoside compound Grant 7,943,788 - Nomura , et al. May 17, 2	2011-05-17
Crystalline form of 1-(.beta.-D-glucopyransoyl)-4-methyl-3-[5-(4-fluorophenyl)-2- thienylmethyl]benzene hemihydrate Grant 7,943,582 - Nomura , et al. May 17, 2	2011-05-17
Glucopyranoside Compound App 20110105424 - NOMURA; Sumihiro ; et al.	2011-05-05
Crystalline form of 1-(beta-D-glucopyransoyl)-4-methyl-3-[5-(4-fluorophenyl)-2- thienylmethyl]benzene hemihydrate App 20080146515 - Nomura; Sumihiro ; et al.	2008-06-19
Novel compounds App 20050233988 - Nomura, Sumihiro ; et al.	2005-10-20
Treatment agent for elastic polyurethane fibers and elastic polyurethane fibers treated therewith Grant 6,652,599 - Inuzuka , et al. November 25, 2	2003-11-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.